PMV Pharmaceuticals, Inc.

PMVP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$21-$21-$17-$23
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$2$2$1
Change in WC$1$2-$2$1
Other Non-Cash$1-$1-$1$4
Operating Cash Flow-$20-$18-$18-$17
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases-$20-$31-$16-$38
Inv. Sales/Matur.$32$42$44$45
Other Inv. Act.$0$0$0$0
Investing Cash Flow$12$11$29$8
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$0$0$0$0
Forex Effect$0-$0$0-$0
Net Chg. in Cash-$8-$7$10-$9
Supplemental Information
Beg. Cash$44$51$41$50
End Cash$36$44$51$41
Free Cash Flow-$20-$18-$18-$17